Researchers discover a mechanism of drug resistance

Dec 12, 2011
The mold Penicillium brevicompactum produces chemicals such as mycophenolic acid that are toxic to other microbes. Credit: Kristian Fog Nielsen, The Technical University of Denmark

(PhysOrg.com) -- Antibiotics are used for everything from squelching strep throat to suppressing the immune system after an organ transplant. Many antibiotics are produced by molds similar to those found on a slice of bread or Roquefort cheese.  Penicillium molds are best known for making penicillin, but also produce the not-so-famous mycophenolic acid, a billion-dollar drug used to ward off organ rejection.

However, mycophenolic acid also poisons most microbes, which has had scientists wondering how molds that produce mycophenolic acid can grow in its presence. This general problem is only understood in a few cases. Understanding how some microbes resist high concentrations of is important to designing new drugs and deciding how and when to prescribe existing drugs.

Xin Sun, a Ph.D. student in Biology Professor Liz Hedstrom’s laboratory, together with Bjarne Gram Hansen of the Technical University of Denmark, got down to the molecular level to unearth that answer for mycophenolic acid production. Their research was recently reported in The Journal of Biological Chemistry and the Biochemical Journal.

Every drug has a target — in this case a protein to which the drug binds, blocking its normal function.  In the case of mycophenolic acid, the target is the protein IMPDH, an enzyme found in every organism.  The faster an organism is growing, the more IMPDH it needs.  When an infection occurs, immune cells need to grow, so they produce more IMPDH.

Unlike most microbes, Penicillium have two copies of IMPDH.

“What Xin Sun did was to show that this second IMPDH is in fact resistant to mycophenolic acid,” says Hedstrom.  “What was puzzling is that you’d expect a change in the drug binding site, but here the drug binding site is identical in both sensitive and resistant targets. Instead, the underlying function of the second IMPDH has changed in clever and sophisticated ways so the drug is no longer effective.”

These findings also provide new insights into another scientific mystery, how antibiotic production evolved in the first place.  The team hypothesizes that Penicillium gained the second IMPDH through mutation (duplication), which allowed them to make small amounts of mycophenolic acid.  Over time, the second IMPDH evolved to become more resistant, allowing the mold to make more mycophenolic

Explore further: Breakthrough points to new drugs from nature

add to favorites email to friend print save as pdf

Related Stories

Cancer drug target is promising lead for new TB treatments

Nov 17, 2010

A key enzyme in Mycobacterium tuberculosis that enables the microbe to reproduce rapidly could be a golden target for new drugs against tuberculosis (TB), according to a study published in Microbiology on 17 November. ...

Targeting a waterborne foe

Apr 25, 2010

Discovered in 1976, cryptosporidium lurks worldwide in water, contaminating swimming pools, water parks, and drinking water supplies. Although it has even been featured on the comedy show The Colbert Report, it is no laughing ...

Microwaves to improve drug delivery

Aug 18, 2011

A team of Swinburne researchers has shown that low-temperature microwaves can be used to open up pores in bacterial cells, which could lead to significant improvements in the design of drug delivery systems.

New knowledge will boost fight against superbug

Sep 07, 2011

A breakthrough in the fight against drug-resistant infections is one step closer following the discovery of the structure of NDM-1: a vicious form of bacteria that is currently resistant to the most powerful antibiotics available.

Recommended for you

Breakthrough points to new drugs from nature

8 hours ago

Researchers at Griffith University's Eskitis Institute have developed a new technique for discovering natural compounds which could form the basis of novel therapeutic drugs.

World's first successful visualisation of key coenzyme

8 hours ago

Japanese researchers have successfully developed the world's first imaging method for visualising the behaviour of nicotine-adenine dinucleotide derivative (NAD(P)H), a key coenzyme, inside cells. This feat ...

User comments : 0

More news stories

Breakthrough points to new drugs from nature

Researchers at Griffith University's Eskitis Institute have developed a new technique for discovering natural compounds which could form the basis of novel therapeutic drugs.

A greener source of polyester—cork trees

On the scale of earth-friendly materials, you'd be hard pressed to find two that are farther apart than polyester (not at all) and cork (very). In an unexpected twist, however, scientists are figuring out ...

A beautiful, peculiar molecule

"Carbon is peculiar," said Nobel laureate Sir Harold Kroto. "More peculiar than you think." He was speaking to a standing-room-only audience that filled the Raytheon Amphitheater on Monday afternoon for the ...

Researchers see hospitalization records as additional tool

Comparing hospitalization records with data reported to local boards of health presents a more accurate way to monitor how well communities track disease outbreaks, according to a paper published April 16 in the journal PLOS ON ...

Ebola virus in Africa outbreak is a new strain

Scientists say that the Ebola (ee-BOH'-lah) virus that has killed scores of people this year in Guinea (GIH'-nee) is a new strain. That means it did not spread there from outbreaks in some other African nations.